Who owns INHIBRX BIOSCIENCES INC COM?
- Ticker: INBX
- CUSIP Number: 45720n103
Tip: Access positions for across all investors
Analyze quarterly positions in Inhibrx Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Inhibrx Biosciences stock
Who bought or sold INHIBRX BIOSCIENCES INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Viking Global Investors | 1.8M | $28M | 0% | Dec 2024 |
|
| Perceptive Advisors | 1.1M | $16M | 0% | Dec 2024 |
|
| BlackRock | 832k | $13M | 16% | Dec 2024 |
|
| HighTower Advisors | 782k | $12M | 538% | Dec 2024 |
|
| Vanguard Group | 608k | $9.4M | 15% | Dec 2024 |
|
| Walleye Trading Advisors | 580k | $8.9M | 5% | Dec 2024 |
|
| Sofinnova Ventures | 527k | $8.1M | -2% | Dec 2024 |
|
| Slotnik Capital | 388k | $6.0M | 5% | Dec 2024 |
|
| Millennium Management | 258k | $4.0M | -11% | Dec 2024 |
|
| Geode Capital Management | 255k | $3.9M | 2% | Dec 2024 |
|
| Caption Management | 200k | $3.1M | 0% | Dec 2024 |
|
| Castalian Partners | 192k | $2.9M | 100% | Dec 2024 |
|
| State Street Corporation | 176k | $2.7M | 10% | Dec 2024 |
|
| Kennedy Capital Management | 166k | $2.6M | 0% | Dec 2024 |
|
| Arrowpoint Asset Management | 161k | $2.5M | 2% | Dec 2024 |
|
| Schonfeld Strategic Advisors | 144k | $2.2M | 0% | Dec 2024 |
|
| Acadian Asset Management | 144k | $2.2M | 165% | Dec 2024 |
|
| Partner Fund Management | 136k | $2.1M | 0% | Dec 2024 |
|
| Northern Trust | 116k | $1.8M | 3% | Dec 2024 |
|
| Susquehanna International | 103k | $1.6M | -31% | Dec 2024 |
|
| Qube Research & Technologies | 91k | $1.4M | -17% | Dec 2024 |
|
| Jane Street | 88k | $1.4M | -10% | Dec 2024 |
|
| CSS | 73k | $1.1M | -48% | Dec 2024 |
|
| Credit Industriel Et Commercial | 64k | $989k | 100% | Dec 2024 |
|
| Goldman Sachs Group | 57k | $885k | 164% | Dec 2024 |
|
| Russell Investments | 54k | $837k | -35% | Dec 2024 |
|
| Marshall Wace | 54k | $825k | -41% | Dec 2024 |
|
| Bank of New York Mellon | 51k | $792k | 100% | Dec 2024 |
|
| Rangeley Capital | 49k | $761k | 100% | Dec 2024 |
|
| Ikarian Capital | 42k | $649k | 0% | Dec 2024 |
|
| Morgan Stanley | 40k | $616k | -83% | Dec 2024 |
|
| FMR | 39k | $597k | 9% | Dec 2024 |
|
| Alpha Wealth Funds | 39k | $541k | -50% | Mar 2025 |
|
| Yakira Capital Management | 36k | $557k | 0% | Dec 2024 |
|
| Citadel Advisors | 36k | $556k | -34% | Dec 2024 |
|
| Murchinson | 34k | $520k | 0% | Dec 2024 |
|
| GSA Capital Partners | 34k | $520k | -19% | Dec 2024 |
|
| Charles Schwab Investment Management | 33k | $503k | 0% | Dec 2024 |
|
| Birchview Capital | 32k | $495k | 0% | Dec 2024 |
|
| Wetherby Asset Management | 31k | $472k | -6% | Dec 2024 |
|
| Boothbay Fund Management | 28k | $435k | 0% | Dec 2024 |
|
| Fort Hoosac Management | 28k | $433k | 0% | Dec 2024 |
|
| Nuveen Asset Management | 25k | $385k | -39% | Dec 2024 |
|
| Meridian Wealth Advisors | 25k | $385k | 100% | Dec 2024 |
|
| Empirical Financial Services, LLC d/b/a Empirical Wealth Management | 23k | $348k | 100% | Dec 2024 |
|
| JBF Capital | 21k | $323k | 0% | Dec 2024 |
|
| CI Private Wealth | 21k | $316k | 48% | Dec 2024 |
|
| Walleye Trading | 20k | $303k | -64% | Dec 2024 |
|
| Deutsche Bank Aktiengesellschaft | 20k | $302k | 15973% | Dec 2024 |
|
| Barclays | 19k | $289k | 17% | Dec 2024 |
|
| Alliancebernstein | 18k | $276k | 0% | Dec 2024 |
|
| UBS Group | 18k | $274k | 194% | Dec 2024 |
|
| Pekin, Singer Strauss Asset Management | 18k | $273k | -31% | Dec 2024 |
|
| Rhumbline Advisers | 15k | $216k | 4% | Mar 2025 |
|
| Bank of America Corporation | 12k | $191k | 22% | Dec 2024 |
|
| Citigroup | 10k | $154k | 7% | Dec 2024 |
|
| Exchange Traded Concepts | 9.1k | $128k | -5% | Mar 2025 |
|
| Bnp Paribas Arbitrage, Snc | 8.3k | $128k | 7% | Dec 2024 |
|
| MetLife Investment Advisors | 7.7k | $118k | 31% | Dec 2024 |
|
| Jpmorgan Chase & Co | 7.6k | $117k | 48% | Dec 2024 |
|
| Mirae Asset Global Etfs Holdings | 6.7k | $103k | 17% | Dec 2024 |
|
| Wells Fargo & Company | 6.6k | $102k | 34% | Dec 2024 |
|
| Corebridge Financial | 5.8k | $89k | 100% | Dec 2024 |
|
| State of Wyoming | 5.4k | $83k | 100% | Dec 2024 |
|
| New York State Common Retirement Fund | 3.5k | $53k | 0% | Dec 2024 |
|
| China Universal Asset Management | 3.1k | $47k | 100% | Dec 2024 |
|
| Natixis | 2.0k | $31k | 0% | Dec 2024 |
|
| Pnc Financial Services | 1.8k | $28k | 90% | Dec 2024 |
|
| Royal Bank of Canada | 1.3k | $21k | -30% | Dec 2024 |
|
| Simplex Trading | 1.1k | $17k | -47% | Dec 2024 |
|
| Legal & General Group | 1.0k | $16k | 0% | Dec 2024 |
|
| Tower Research Capital | 967.00 | $15k | 8% | Dec 2024 |
|
| California State Teachers Retirement System | 858.00 | $13k | 0% | Dec 2024 |
|
| Summit Investment Advisors | 853.00 | $13k | 0% | Dec 2024 |
|
| NISA Investment Advisors | 568.00 | $8.7k | 11% | Dec 2024 |
|
| GAMMA Investing | 490.00 | $6.9k | 610% | Mar 2025 |
|
| Mirae Asset Global Investments | 482.00 | $7.2k | 100% | Dec 2024 |
|
| Versant Capital Management | 396.00 | $5.5k | 100% | Mar 2025 |
|
| Amalgamated Bank | 362.00 | $6.0k | 0% | Dec 2024 |
|
| Gf Fund Management | 304.00 | $4.7k | 100% | Dec 2024 |
|
| FNY Investment Advisers | 250.00 | $3.0k | 0% | Mar 2025 |
|
| CWM | 243.00 | $4.0k | -56% | Dec 2024 |
|
| Creative Planning | 222.00 | $3.4k | 100% | Dec 2024 |
|
| Sterling Capital Management | 158.00 | $2.4k | 2533% | Dec 2024 |
|
| Quadrant Capital | 146.00 | $2.2k | -15% | Dec 2024 |
|
| Group One Trading | 144.00 | $2.2k | 0% | Dec 2024 |
|
| Signature | 128.00 | $2.0k | -31% | Dec 2024 |
|
| Us Bancorp | 123.00 | $1.9k | -95% | Dec 2024 |
|
| Zurcher Kantonalbank | 118.00 | $1.8k | 0% | Dec 2024 |
|
| Huntington National Bank | 90.00 | $1.4k | 0% | Dec 2024 |
|
| Advisor Group Holdings | 85.00 | $1.3k | 0% | Dec 2024 |
|
| Measured Risk Portfolios | 37.00 | $569.999800 | 100% | Dec 2024 |
|
| Lindbrook Capital | 17.00 | $262.000600 | 0% | Dec 2024 |
|
| EverSource Wealth Advisors | 6.00 | $91.999800 | 0% | Dec 2024 |
|
| IFP Advisors | 4.00 | $62.000000 | 100% | Dec 2024 |
|
| True Wealth Design | 3.00 | $47.000100 | -94% | Dec 2024 |
|
| Rothschild Investment | 1.00 | $14.000000 | -50% | Mar 2025 |
|
| Farther Finance Advisors | 1.00 | $14.000000 | 0% | Mar 2025 |
|
| Quest Partners | 1.00 | $15.000000 | -67% | Dec 2024 |
|
Who sold out of Inhibrx Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Equitec Proprietary Markets | Sep 2024 | 96k | $1.5M |
| Renaissance Technologies | Sep 2024 | 25k | $393k |
| Squarepoint Ops | Sep 2024 | 21k | $330k |
| Jacobs Levy Equity Management | Sep 2024 | 21k | $321k |
| AQR Capital Management | Sep 2024 | 13k | $204k |
| ALPS Advisors | Sep 2024 | 11k | $172k |
| Erste Asset Management GmbH | Sep 2024 | 2.2k | $34k |
| Covestor | Sep 2024 | 1.7k | $26k |
| Larson Financial Group | Sep 2024 | 581.00 | $9.1k |
| Nelson, Van Denburg & Campbell Wealth Management | Dec 2024 | 248.00 | $3.8k |
| Capital Performance Advisors | Sep 2024 | 61.00 | $954.997700 |
| Bessemer | Sep 2024 | 12.00 | $0 |
| SRS Capital Advisors | Sep 2024 | 10.00 | $157.000000 |